Skip to main content

MYDA Advisors LLC

Position in BHVN — Biohaven Ltd.

CIK 1589689 WOODMERE, NY

Position in BHVN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,112,000
+$6,748,500 QoQ
Shares Held
1,150,000
-6.1% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
4.81%
of 13F equity value
Holder Rank
#29
of 294 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BHVN Over Time

Shares Held

Position Value (USD)

Derivatives in BHVN

reported options exposure · as of Jun 30, 2026
CallValue
$595,200
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MYDA Advisors LLC holds $47,243,871 across 14 Biotechnology names. BHVN ranks #1 (36.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
This page
1,150,000 $17,112,000

All Filings in BHVN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,112,000 1,150,000
2026-06-30 $595,200 40,000
2026-03-31 $10,363,500 1,225,000
2025-12-31 $14,112,500 1,250,000
2025-12-31 $112,900 10,000
2025-09-30 $1,801,200 120,000
2025-09-30 $1,125,750 75,000
2024-12-31 $2,016,900 54,000
2024-09-30 $3,497,900 70,000
2024-06-30 $3,713,970 107,000
2024-03-31 $5,825,305 106,515
2023-12-31 $5,350,000 125,000
2023-09-30 $2,210,850 85,000
2023-06-30 $1,674,400 70,000
2023-03-31 $204,900 15,000